Altheus Therapeutics Inc — Form D
Altheus Therapeutics Inc of Oklahoma City, OK, a company, filed a Form D exempt-offering notice with the SEC on 2012-03-09. The offering totals $7.7M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-03-09
- Form: D
- Accession: 0001140361-12-014470
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $7.7M
- Amount sold: $5.3M
- Remaining: $2.4M
- Minimum investment: $967
- Investors: 12
- Date of first sale: 2012-02-24
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-174656
Issuer
- Name: Altheus Therapeutics Inc
- CIK: 0001414163
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 755 Research Parkway, Oklahoma City, OK, 73104
- Phone: (405) 319-8180
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| William Paiva | Director | Broken Arrow, OK |
| Dennis Schafer | Director | Amsterdam, P7 |
| Dennis Schafer | Executive Officer | Amsterdam, P7 |
| William A Paiva | Director | Tulsa, OK |
| Douglas A Branch | Director | OKLAHOMA CITY, OK |
| Douglas A Branch | Executive Officer | OKLAHOMA CITY, OK |
| William L Paiva | Director | Tulsa, OK |
| Dayton T Reardan | Executive Officer | Oklahoma City, OK |
| Alpha A BioPartners, Inc. | Promoter | Palo Alto, CA |
| Alpha BioPartners Inc. | Promoter | Palo Alto, CA |
| Brian L Clevinger | Director | St. Louis, MO |
| Brian L Clevinger | Executive Officer | St. Louis, MO |
| Dennis L Schafer | Director | Oklahoma City, OK |
| Dennis L Schafer | Executive Officer | Oklahoma City, OK |
| Thomas L Shoaf | Director | St. Louis, MO |
| Richard F Harty, MD | Executive Officer | Oklahoma City, OK |
| Richard F Harty, MD | Promoter | Oklahoma City, OK |
| James L Schoeneck | Director | San Diego, CA |
| James Schoeneck | Director | San Diego, CA |
Other filings by this issuer (8)
More